253 results on '"Dehais, Caroline"'
Search Results
2. An AI-powered blood test to detect cancer using nanoDSF
3. Hybrid [18F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After Radiotherapy
4. Chemotherapy is an efficient treatment in primary CNS MALT lymphoma
5. Neuro-Psychological Outcome of ICU-Admitted COVID-19 Patients Presenting With CNS Complications
6. Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors
7. Mechanisms and therapeutic implications of hypermutation in gliomas
8. A threshold for mitotic activity and post‐surgical residual volume defines distinct prognostic groups for astrocytoma IDH‐mutant
9. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma
10. Supplementary Tables from Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma
11. Comment gérer le traitement anticoagulant chez les patients atteints de tumeurs cérébrales primitives ou de métastases cérébrales ?
12. T2‐Fluid‐attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.
13. In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of IDH-Mutant Diffuse Gliomas
14. Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network Study
15. PATH-16. THRESHOLDS OF MITOTIC ACTIVITY AND POST-SURGERY RESIDUAL VOLUME ARE INDEPENDENT PROGNOSTIC FACTORS IN ASTROCYTOMA IDH-MUTANT
16. Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing
17. Long-term outcomes of refractory neurosarcoidosis treated with infliximab
18. Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study
19. Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
20. A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas.
21. Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
22. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort
23. Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas
24. Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study.
25. La mélanomatose neuro-méningée : un diagnostic difficile
26. Humanpegivirus identifié chez 4 patients transplantés présentant un tableau sévère de neuromyélite optique, un rôle pathogène pour ce virus ?
27. The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centre
28. Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma
29. NCOG-09. PREDICTIVE GERIATRIC FACTORS IN ELDERLY PATIENTS TREATED FOR IDH-MUTANT HIGH-GRADE GLIOMAS: A FRENCH POLA NETWORK STUDY
30. Sustained Tumor Control With MAPK Inhibition in BRAF V600–Mutant Adult Glial and Glioneuronal Tumors
31. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis
32. Herpes simplex encephalitis in glioma patients: a challenging diagnosis
33. Hybrid [18F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After Radiotherapy.
34. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma
35. Radiotherapy‐PCV versus radiotherapy‐temozolomide for IDH ‐mutant anaplastic astrocytoma: a retrospective multicentre analysis of the French POLA cohort
36. Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma
37. Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.
38. Une tumeur gliale qui remue ses méninges !
39. Infection à pegivirus (HPgV) responsable d’un tableau de myélite et névrite optique chez un patient immunodéprimé
40. Série de 4 cas de tumeurs glioneuronales leptoméningées diffuses chez l’adulte
41. An AI-Powered Blood Test to Detect Cancer Using NanoDSF
42. Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort
43. Severe COVID-19-related encephalitis can respond to immunotherapy
44. The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study
45. Nitrosourea-based chemotherapy for low grade gliomas failing initial treatment with temozolomide
46. Effet rebond après arrêt du Fingolimod dans une forme secondairement progressive de sclérose en plaques
47. Abstract 5705: Mechanisms and therapeutic implications of hypermutation in gliomas
48. An AI-powered blood test to detect cancer using nanoDSF
49. 5-Azacitidine in patients with IDH1/2-mutant recurrent glioma
50. Germline mutations in the new E1’ cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.